Using Real-World Research to Study the Impact of Chronic Daily Therapy Discontinuation in Cystic Fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Using Real-World Research to Study the Impact of Chronic Daily Therapy Discontinuation in Cystic Fibrosis

Published:2024-06 Issue: Volume: Page:100080
ISSN:2949-7892
Container-title:CHEST Pulmonary
language:en
Short-container-title:CHEST Pulmonary

Author:

Rosen Bradley H.^ORCID,Psoter Kevin J.^ORCID,Sabadosa Kathryn A.,Hergenroeder Georgene E.,Bendy Lisa L.^ORCID,Luo Nell M.,Zhang Connie^ORCID,Ren Clement L.^ORCID,Brown Cynthia D.^ORCID

Funder

Cystic Fibrosis Foundation

Publisher

Elsevier BV

Reference17 articles.

1. Characterising burden of treatment in cystic fibrosis to identify priority areas for clinical trials;Davies;J Cyst Fibros,2020

2. Treatment complexity in cystic fibrosis: trends over time and associations with site-specific outcomes;Sawicki;J Cyst Fibros,2013

3. Managing treatment complexity in cystic fibrosis: challenges and opportunities;Sawicki;Pediatr Pulmonol,2012

4. A refresh of the top 10 research priorities in cystic fibrosis;Rowbotham;Thorax,2023

5. VX-445-tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles;Keating;N Engl J Med,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP